Editas Medicine SG&A Expense (Quarterly) Trends

Editas Medicine Inc (EDIT)

5.208 +0.04 (+0.73%) USD | NASDAQ | May 31, 16:00

5.20 -0.01 (-0.14%) After-Hours: 20:00

SG&A Expense (Quarterly) Chart

Historical SG&A Expense (Quarterly) Data

View and export this data back to 2014. Upgrade now.

Date	Value
March 31, 2024	19.34M
December 31, 2023	14.46M
September 30, 2023	14.99M
June 30, 2023	17.20M
March 31, 2023	23.01M
December 31, 2022	17.98M
September 30, 2022	16.24M
June 30, 2022	16.94M
March 31, 2022	19.54M
December 31, 2021	16.53M
September 30, 2021	16.18M
June 30, 2021	22.03M
March 31, 2021	21.44M
December 31, 2020	15.79M
September 30, 2020	19.94M
June 30, 2020	14.08M
March 31, 2020	17.77M
December 31, 2019	16.92M
September 30, 2019	15.73M

Date	Value
June 30, 2019	14.41M
March 31, 2019	17.49M
December 31, 2018	13.18M
September 30, 2018	13.33M
June 30, 2018	14.31M
March 31, 2018	14.19M
December 31, 2017	13.68M
September 30, 2017	12.64M
June 30, 2017	11.89M
March 31, 2017	12.29M
December 31, 2016	13.05M
September 30, 2016	11.30M
June 30, 2016	12.16M
March 31, 2016	9.762M
December 31, 2015	7.339M
September 30, 2015	4.202M
June 30, 2015	3.281M
March 31, 2015	3.273M
December 31, 2014	2.793M

SG&A Expense Definition

SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.

Read full definition.

SG&A Expense (Quarterly) Range, Past 5 Years

14.08M

Minimum

Jun 2020

23.01M

Maximum

Mar 2023

17.53M

Average

16.93M

Median

SG&A Expense (Quarterly) Benchmarks